Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-lipoic acid for glycaemic control in type 2 diabetes
2005-001543-36Phase 4Completed
- Sponsor
- NHS Lothian
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Alpha-lipoic acid plus usual treatment with Placebo plus usual treatment (2 arms). Primary endpoint: Change in HbA1c. Started Mar 2006; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-001543-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001543-36.